Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 48.64% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -393.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -24.84% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.01% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,578.91% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 45.00% |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | -165.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165.57% |
| Dec 31, 2025 | 518.62% |
| Sep 30, 2025 | 263.39% |
| Jun 30, 2025 | 18.61% |
| Mar 31, 2025 | -493.67% |
| Dec 31, 2024 | 670.88% |
| Sep 30, 2024 | -23.75% |
| Jun 30, 2024 | -258.41% |
| Mar 31, 2024 | 6.14% |
| Dec 31, 2023 | -120.52% |
| Sep 30, 2023 | 530.12% |
| Jun 30, 2023 | -17.93% |
| Mar 31, 2023 | -433.06% |
| Dec 31, 2022 | -53.66% |
| Sep 30, 2022 | -90.59% |
| Jun 30, 2022 | -47.18% |
| Mar 31, 2022 | -108.56% |
| Dec 31, 2021 | 0.95% |
| Sep 30, 2021 | -38.16% |
| Jun 30, 2021 | 512.03% |